A Novel Drug Delivery System: Hyodeoxycholic Acid-Modified Metformin Liposomes for Type 2 Diabetes Treatment

Metformin is a first-line drug for the clinical treatment of type 2 diabetes; however, it always leads to gastrointestinal tolerance, low bioavailability, short half-life, etc. Liposome acts as an excellent delivery system that could reduce drug side effects and promote bioavailability. Hyodeoxychol...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Minghao, Gou, Tingting, Chen, Yuchen, Xu, Min, Chen, Rong, Zhou, Tao, Liu, Junjing, Peng, Cheng, Ye, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055618/
https://www.ncbi.nlm.nih.gov/pubmed/36985444
http://dx.doi.org/10.3390/molecules28062471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055618/
https://www.ncbi.nlm.nih.gov/pubmed/36985444
http://dx.doi.org/10.3390/molecules28062471

Ejemplares similares